Advancing Global Access to Cancer Medicines
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Access to cancer medicines varies considerably across countries, even after treatments receive regulatory approval. This panel will examine the clinical, financial, regulatory, and supply-related obstacles that delay treatment and discuss approaches that can improve access.
Hear practical experiences from each panelist’s country and professional role in an open discussion, followed by time for your questions.
Meet the International Faculty
Moderator: Marko Skelin, MPharm, PhD | Associate Professor, University of Rijeka – Faculty of Medicine | Croatia
Dylan Burke, MPharm | Business Development Manager, Orspec Pharma (Uniphar) | Australia
Laure-Anne Teuwen, MD | Medical Oncologist, UZA | Belgium
Joseph Williams | NMP Pharmacy Lead, The Christie NHS Foundation Trust | United Kingdom
Brenda Dooley | Chief Executive Officer | AXIS The Reimbursement Experts | United Kingdom & Ireland
Save the date for more upcoming webinars from this series
December 14 | Antibody Drug Conjugates for Platinum Resistant Ovarian Cancer: Emerging Evidence and Challenges
January 20 | From Data to Decisions: The Power of AI in Oncology
February 17 | The Challenging Landscape of Hematologic Malignancies: From Discovery to Clinical Practice
Additional Upcoming Webinars
Upcoming Webinar
Enhancing Survivorship: Caring for Patients after Allogeneic HCT
November 9, 2026 | 2:00 PM
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields
Was this page
helpful?
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields